The Chemotherapy Induced Neutropenia (CIN) Treatment Market is witnessing steady growth as healthcare providers increasingly prioritize supportive therapies that reduce the complications associated with chemotherapy. Chemotherapy-induced neutropenia is one of the most common dose-limiting toxicities experienced by cancer patients, significantly increasing the risk of serious infections and...